国际英语新闻:Brazilian economy is recovering fast: central bank
RIO DE JANEIRO, May 21 (Xinhua) -- Brazil's economic activities are returning to normal levels, according to a study released on Friday by the Central Bank of Brazil.
According to the bank, the Brazilian economy's recovery from the effects of the international financial crisis is evidenced by the GDP growth registered in the second, third and fourth quarters of 2009, as well as the preliminary results registered in 2010.
Earlier in the week, the bank released its Economic Activity Indicator (IBC-Br), which indicated a growth of 2.38 percent in the first quarter of 2010 compared with the fourth quarter of 2009, and a growth of 9.85 percent compared with the same period last year.
For the past 12 months, the bank estimated a year-on-year growth of 3.06 percent.
The central bank said that the economic activity has increased in all the five regions of Brazil. In the most developed southeastern region where a third of the country's industries is concentrated, the growth is mainly propelled by the recuperation of the industrial sector.
The central bank said the industrial expansion can be attributed to the increasing demand in the domestic market and the improvements registered in the credit and job markets.
In the other four regions, the rising demand and the expansion of credit have led to the increased economic activity, according to the bank.
相关文章
- 欧美文化:Russian FM visits Algeria to mark 60th anniversary of ties
- 欧美文化:Spanish government sacks spy chief after phone tapping scandal
- 欧美文化:Moroccan, Egyptian FMs discuss prospects of bolstering cooperation
- 欧美文化:Macron visits Berlin on first foreign trip after re-election
- 欧美文化:Ukrainian president, Swedish PM discuss defense support for Ukraine over phone
- 欧美文化:Serbia, China commemorate journalists killed in NATO bombing 23 years ago
- 欧美文化:Two suspects arrested for killing 3 Israelis in stabbing attack
- 欧美文化:Israel celebrates 74th Independence Day
- 欧美文化:Putin, Bennett discuss Ukraine over phone
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk